Tactile Versus Hysteroscopic Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding
The clinical trial compares the efficacy and safety of Tactile Electrosurgical Ablation (TEA) against traditional Hysteroscopic Electrosurgical Ablation for treating dysfunctional uterine bleeding (DUB) in women aged 40-50. Given that DUB affects up to 30% of women during their reproductive years, there is a significant market opportunity for effective, less invasive treatments. TEA presents as a cost-effective alternative, particularly in resource-limited settings, which may appeal to healthcare systems facing budget constraints. The trial's completion and positive outcomes could position TEA as a viable competitor to existing surgical options, potentially influencing treatment guidelines and expanding market share in gynecological interventions.
Indication: Dysfunction Uterine Bleeding
Modality: medical device
Target: Tactile electrosurgical ablation (TEA) technique for dysfunctional uterine bleeding (DUB)
Sponsor: Mostafa Hussein
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jun 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Tactile electrosurgical ablation (TEA) technique for dysfunctional uterine bleeding (DUB)
View original source fields
Condition raw: Dysfunction Uterine Bleeding
Condition normalized: Dysfunction Uterine Bleeding
Modality raw: medical device
Modality normalized: medical device
Target raw: Tactile electrosurgical ablation (TEA) technique for dysfunctional uterine bleeding (DUB)
Target normalized: Tactile electrosurgical ablation (TEA) technique for dysfunctional uterine bleeding (DUB)